Faculty profile

Habib Khan

ResearcherWestern University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Western University directory, so their courses may be missing. Find their university profile.

Habib Khan

Researcher

Health Sciences

Western University

London, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
11 publications in the last five years, latest in 2025.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2024.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

179

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their Western University profile.

Atrial Fibrillation Av Node Ablation Conduction System Pacing Electrophysiology Heart Failure Pharmacological Therapy Rate Control

Latest papers

Flecainide for the Treatment of Andersen-Tawil Syndrome
JACC: Clinical Electrophysiology · 2025
Navigating the brain: How cerebral blood flow shifts with task complexity.
PloS one · 2025
Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure
New England Journal of Medicine · 2024

All 14 publications

Latest funding

Precision Diagnosis and Management of Cardiogenetics: The Hearts in Rhythm Organization (HiRO)
CIHR · 2026 · Co-investigator
$1,095,100
EAST-STROKE: A Randomized Controlled Trial of Rhythm Control vs. Standard of Care for Atrial Fibrillation in Acute Ischemic Stroke
CIHR · 2025 · Co-investigator
$971,550
Resynchronization for Ambulatory Heart Failure Trial in patients with Chronic Atrial Fibrillation - Pharmacological rate control vs. Pace and Ablate with Conduction System Pacing
CIHR · 2024 · Nominated PI
$2,007,055

All 7 grants and awards

14 publications.

Flecainide for the Treatment of Andersen-Tawil Syndrome

Mann TD, Yoruk A, Neves RA, Bergman AT, Bos MJ, van der Werf C, Gollob MH, Roberts JD, Khan H, Sanatani S

JACC: Clinical Electrophysiology20259 citations

DOI: 10.1016/j.jacep.2025.03.020

Navigating the brain: How cerebral blood flow shifts with task complexity.

Fitzgibbon-Collins LK, Noguchi M, Coombs GB, Hughson RL, Guest C, Amelard R, McArthur D, Peters S, Best S, Borrie M, Khan H, Shoemaker JK, Bhangu J

PloS one2025

DOI: 10.1371/journal.pone.0333684 PMID: 41129496

Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure

Lam NHN, Talajic M, McCarron CE, Redpath CJ, Wells G, Sivakumaran S, Khan H, Parkash R, Exner DV, Thibault B

New England Journal of Medicine202450 citations

DOI: 10.1056/nejmoa2304542

High-Risk Nonclassical Long-QT Syndrome Genotypes: Spectrum of Genetic and Phenotypic Features

Abdulrahman A, Davies B, Khan H, Sanatani S, Tadros R, Talajic M, Cadrin-Tourigny J, Atallah J, Lee D, Gardner M

Circulation. Genomic and precision medicine20241 citations

DOI: 10.1161/circgen.124.004554

Long-term clinical outcomes and cost-effectiveness of catheter vs thoracoscopic surgical ablation in long-standing persistent atrial fibrillation using continuous cardiac monitoring: CASA-AF randomized controlled trial.

Boyalla V, Haldar S, Khan H, Kralj-Hans I, Banya W, Lord J, Satishkumar A, Bahrami T, De Souza A, Clague JR, Francis DP, Hussain W, Jarman JW, Jones DG, Chen Z, Mediratta N, Hyde J, Lewis M, Mohiaddin R, Salukhe TV, Markides V, McCready J, Gupta D, Wong T, CASA-AF Investigators

Heart rhythm2024

DOI: 10.1016/j.hrthm.2024.05.022 PMID: 38763376

The Diagnostic Utility of Holter Monitoring in Catecholaminergic Polymorphic Ventricular Tachycardia.

Naderi B, Davies B, Khan H, Sanatani S, Andrade JG, Bennett MT, Hawkins NM, Chakrabarti S, Yeung-Lai-Wah JA, Deyell MW, Laksman ZWM, Roston TM, Krahn AD

JACC. Clinical electrophysiology2024

DOI: 10.1016/j.jacep.2024.06.028 PMID: 39207284

The Prevalence and Characteristics of Arrhythmic Mitral Valve Prolapse in Patients With Unexplained Cardiac Arrest

Alqarawi W, Tadros R, Roberts JD, Cheung CC, Green MS, Burwash IG, Steinberg C, Healey JS, Khan H, McIntyre C

JACC: Clinical Electrophysiology202314 citations

DOI: 10.1016/j.jacep.2023.08.017

Incremental value of the signal-averaged ECG for diagnosing arrhythmogenic cardiomyopathy

Pearman CM, Lee D, Davies B, Khan H, Tadros R, Cadrin-Tourigny J, Roberts JD, Sanatani S, Simpson C, Angaran P

Heart Rhythm20239 citations

DOI: 10.1016/j.hrthm.2022.10.005

Importance of genetic testing in unexplained cardiac arrest

Grondin S, Davies B, Cadrin-Tourigny J, Steinberg C, Cheung CC, Jorda P, Healey JS, Green MS, Sanatani S, Alqarawi W

European Heart Journal202272 citations

DOI: 10.1093/eurheartj/ehac145

Sex Differences and Utility of Treadmill Testing in Long‐QT Syndrome

Yee LA, Han H, Davies B, Pearman CM, Laksman ZWM, Roberts JD, Steinberg C, Tadros R, Cadrin‐Tourigny J, Simpson CS

Journal of the American Heart Association20228 citations

DOI: 10.1161/jaha.121.025108

Something wrong or missing on this profile? Suggest a correction

Habib Khan

Research

Latest papers

Latest funding

Flecainide for the Treatment of Andersen-Tawil Syndrome

Navigating the brain: How cerebral blood flow shifts with task complexity.

Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure

High-Risk Nonclassical Long-QT Syndrome Genotypes: Spectrum of Genetic and Phenotypic Features

Long-term clinical outcomes and cost-effectiveness of catheter vs thoracoscopic surgical ablation in long-standing persistent atrial fibrillation using continuous cardiac monitoring: CASA-AF randomized controlled trial.

The Diagnostic Utility of Holter Monitoring in Catecholaminergic Polymorphic Ventricular Tachycardia.

The Prevalence and Characteristics of Arrhythmic Mitral Valve Prolapse in Patients With Unexplained Cardiac Arrest

Incremental value of the signal-averaged ECG for diagnosing arrhythmogenic cardiomyopathy

Importance of genetic testing in unexplained cardiac arrest

Sex Differences and Utility of Treadmill Testing in Long‐QT Syndrome

Precision Diagnosis and Management of Cardiogenetics: The Hearts in Rhythm Organization (HiRO)

EAST-STROKE: A Randomized Controlled Trial of Rhythm Control vs. Standard of Care for Atrial Fibrillation in Acute Ischemic Stroke

Resynchronization for Ambulatory Heart Failure Trial in patients with Chronic Atrial Fibrillation - Pharmacological rate control vs. Pace and Ablate with Conduction System Pacing

Multimodality event prediction in non-ischemic cardiomyopathy

Targeted Therapy with Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Right Ventricular Cardiomyopathy (TARGETED-ARVC)

Optimizing care for individuals and families at risk for heritable cardiac diseases - a planning meeting to build partnerships, exchange knowledge and prioritize research questions

Targeted Therapy with Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Right Ventricular Cardiomyopathy (TARGETED-ARVC)

Frequent collaborators

Shubhayan Sanatani

Jason Roberts

Jeff Healey

Rafik Tadros

Christian Steinberg

Julia Cadrin-Tourigny

Jacqueline Joza

Laura Arbour

William Chan

Martin Green

George Wells

Zachary Laksman

Anne Fournier

George Wells

Andrew Krahn

Girish Nair

George Wells

Ratika Parkash

Aaron So

Guillaume Lettre

Léna Rivard

Sue Peters